Phase II Trial of Subcutaneous Interleukin-2, Subcutaneous Interferon-α, Intravenous Combination Chemotherapy, and Oral Tamoxifen in the Treatment of Metastatic Melanoma: Final Results of Cancer Biotherapy Research Group 94-11
2000 ◽
Vol 15
(5)
◽
pp. 487-494
◽
Keyword(s):
Phase Ii
◽
1999 ◽
Vol 11
(2)
◽
pp. 150-155
◽